Cryptococcal meningitis (CM) is an opportunistic fungal infection associated with human
immunodeficiency virus (HIV) and other forms of immunosuppression. We lack a clear …

Background Cryptococcal meningitis is an uncommon but serious infection with high
mortality and morbidity. Classically described in immunocompromised patients, including …

Background: Interferon-gamma (IFNγ) is of key importance in the immune response to
Cryptococcus neoformans. Mortality related to cryptococcal meningitis remains high, and …

Cryptococcal meningitis (CM) is the primary cause of meningitis in adults with human
immunodeficiency virus (HIV) infection and an emerging disease in HIV-seronegative …

Cryptococcal meningitis (CM) is mostly seen in immunocompromised patients, particularly
human immunodeficiency virus (HIV)-positive patients, but CM may also occur in apparently …

Although the incidence of HIV-associated cryptococcosis has decreased in developed
countries since the introduction of antiretroviral therapy, this disease continues to cause …

Central nervous system cryptococcosis occurs in an estimated 1 million persons in the world
each year, most of whom are human immunodeficiency virus (HIV) positive and reside in …

Cryptococcal meningitis (CM) is a common form of meningitis in sub-Saharan Africa due to
the high prevalence of HIV/AIDS. This report outlines the management of CM with a focus on …

As the diagnosis of cryptococcosis is challenging in low‐prevalence settings, uncovering
predictive factors can improve early diagnosis and timely treatment. The aim of the study …

Introduction Cryptococcal meningitis remains a significant contributor to AIDS-related
mortality despite widened access to antiretroviral therapy. Cryptococcal antigen (CrAg) can …